DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Funds / Innovatus Life Sciences Lending Fund I, LP
Innovatus Life Sciences Lending Fund I, LP
Amounts, each with its basis
- Vintage
- 2017basis: first reported on Form ADV
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised
- Form D sold
- unknownno Form D on record
- First sale
- unknown
- Reported gross assets
- $382MForm ADV, as of Oct 17, 2024; not fund size, not dry powder
- Peak reported gross assets
- $382Mhighest year on the reporting tape
- Owners (ADV)
- 33
- Reported on ADV
- Mar 31, 2017 to Oct 17, 2024
- Structure
- standalone
- Fund of funds (ADV)
- no
- Strategy
- Lending
Lifecycle
Mature
rule: gross assets within 10% of the prior yearmodel: lc-pe-1gav path: 2017,109468672,2018,109468672,2019,111602937,2020,153091044,2021,211193857,2022,338030030,2023,376866950,2024,382133463peak gav: $382Mas of year: $2,024latest gav: $382Mreported years: 8last step change: 0.014age years at as of: 7drawdown from peak: 0first reported year: $2,017
Reported gross assets by year
8 annual rows
| Year | Filed | Type | Gross assets | Owners | Min. investment | Non-US owned | Source | |
|---|---|---|---|---|---|---|---|---|
| 2017 | Mar 31, 2017 | Private Equity Fund | $109M | 11 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2018 | May 23, 2018 | Private Equity Fund | $109M | 11 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2019 | Mar 31, 2019 | Private Equity Fund | $112M | 16 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2020 | Jul 2, 2020 | Private Equity Fund | $153M | 15 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2021 | Mar 31, 2021 | Private Equity Fund | $211M | 26 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2022 | Sep 13, 2022 | Private Equity Fund | $338M | 26 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2023 | Mar 31, 2023 | Private Equity Fund | $377M | 33 | $2.0M | 0% | adviserinfo.sec.gov | |
| 2024 | Oct 17, 2024 | Private Equity Fund | $382M | 33 | $2.0M | 0% | adviserinfo.sec.gov |
Placement agents and principals
0 placement agents, 0 principals
No placement agent or principal collected for this fund yet. Both come from the related persons and sales compensation sections of Form D.
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
- Mar 31, 2017Innovatus Life Sciences Lending Fund I, LP first reported on Form ADV by Innovatus Capital Partners, LLC (Private Equity Fund), GAV $109,468,672Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)